LncRNA SNHG7 promotes glioma cells viability, migration and invasion by regulating miR-342-3p/AKT2 axis

References

• Bleeker FE, Molenaar RJ, Leenstra S. Recent advances in the molecular understanding of glioblastoma. J Neurooncol. 2012;108(1):11–27.
   PubMed Web of Science ®Google Scholar
• Boussiotis VA, Charest A. Immunotherapies for malignant glioma. Oncogene. 2018;37(9):1121–1141.
   PubMed Web of Science ®Google Scholar
• Davis ME. Epidemiology and overview of gliomas. Semin Oncol Nurs. 2018;34(5):420–429.
   PubMed Web of Science ®Google Scholar
• Young RM, Jamshidi A, Davis G, et al. Current trends in the surgical management and treatment of adult glioblastoma. Ann Transl Med. 2015;3(9):121–121.
   PubMed Web of Science ®Google Scholar
• Rigamonti A, Imbesi F, Silvani A, et al. Pattern of care and outcome in elderly patients with glioblastoma: data in 151 patients from 3 Lombardia Hospitals. J Neurol Sci. 2017;378:3–8.
   PubMed Web of Science ®Google Scholar
• Holdhoff M. Discovery of predictive biomarkers in malignant gliomas. Neuro Oncol. 2019;21(9):1089–1090.
   PubMed Web of Science ®Google Scholar
• Xu Y, Tong Y, Zhu J, et al. An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma. BMC Cancer. 2017;17(1):373.
   PubMed Web of Science ®Google Scholar
• Jathar S, Kumar V, Srivastava J, et al. Technological developments in lncRNA biology. Adv Exp Med Biol. 2017;1008:283–323.
   PubMed Web of Science ®Google Scholar
• Kung JTY, Colognori D, Lee JT. Long noncoding RNAs: past, present, and future. Genetics. 2013;193(3):651–669.
   PubMed Web of Science ®Google Scholar
• Xia T, Liao Q, Jiang X, et al. Long noncoding RNA associated-competing endogenous RNAs in gastric cancer. Sci Rep. 2014;4:6088.
   PubMed Web of Science ®Google Scholar
• Shan Y, Ma J, Pan Y, et al. LncRNA SNHG7 sponges MIR-216b to promote proliferation and liver metastasis of colorectal cancer through upregulating GALNT1. Cell Death Dis. 2018;9(7):722.
   PubMed Web of Science ®Google Scholar
• Gao YT, Zhou YC. Long non-coding RNA (lncRNA) small nucleolar RNA host gene 7 (SNHG7) promotes breast cancer progression by sponging miRNA-381. Eur Rev Med Pharmacol Sci. 2019;23(15):6588–6595.
   PubMed Web of Science ®Google Scholar
• Wang YH, Huo BL, Li C, et al. Knockdown of long noncoding RNA SNHG7 inhibits the proliferation and promotes apoptosis of thyroid cancer cells by downregulating BDNF. Eur Rev Med Pharmacol Sci. 2019;23(11):4815–4821.
   PubMed Web of Science ®Google Scholar
• Cheng D, Fan J, Ma Y, et al. LncRNA SNHG7 promotes pancreatic cancer proliferation through ID4 by sponging miR-342-3p. Cell Biosci. 2019;9:28.
   PubMed Web of Science ®Google Scholar
• Deng Y, Zhao F, Zhang Z, et al. Long noncoding RNA SNHG7 promotes the tumor growth and epithelial-to-mesenchymal transition via regulation of miR-34a signals in osteosarcoma. Cancer Biother Radiopharm. 2018;33(9):365–372.
   PubMed Web of Science ®Google Scholar
• Ren J, Yang Y, Xue J, et al. Long noncoding RNA SNHG7 promotes the progression and growth of glioblastoma via inhibition of miR-5095. Biochem Biophys Res Commun. 2018;496(2):712–718.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Gu J-J, Gao G-Z, Zhang S-M. miR-218 inhibits the migration and invasion of glioma U87 cells through the Slit2-Robo1 pathway. Oncol Lett. 2015;9(4):1561–1566.
   PubMed Web of Science ®Google Scholar
• McNeill KA. Epidemiology of brain tumors. Neurol Clin. 2016;34(4):981–998.
   PubMed Web of Science ®Google Scholar
• Bhan A, Soleimani M, Mandal S. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77(15):3965–3917.
   PubMed Web of Science ®Google Scholar
• Sun X, Huang T, Liu Z, et al. LncRNA SNHG7 contributes to tumorigenesis and progression in breast cancer by interacting with miR-34a through EMT initiation and the Notch-1 pathway. Eur J Pharmacol. 2019;856:172407.
   PubMed Web of Science ®Google Scholar
• Li H, Li T, Huang D, et al. Long noncoding RNA SNHG17 induced by YY1 facilitates the glioma progression through targeting miR-506-3p/CTNNB1 axis to activate Wnt/β-catenin signaling pathway. Cancer Cell Int. 2020;20:29.
   PubMed Web of Science ®Google Scholar
• Cui D, Sajan P, Shi J, et al. MiR-148a increases glioma cell migration and invasion by downregulating GADD45A in human gliomas with IDH1 R132H mutations. Oncotarget. 2017;8(15):25345–25361.
   PubMedGoogle Scholar
• Gusyatiner O, Hegi ME. Glioma epigenetics: from subclassification to novel treatment options. Semin Cancer Biol. 2018;51:50–58.
   PubMed Web of Science ®Google Scholar
• Ballantyne MD, McDonald RA, Baker AH. LncRNA/microRNA interactions in the vasculature. Clin Pharmacol Ther. 2016;99(5):494–501.
   PubMed Web of Science ®Google Scholar
• Fu C, Li D, Zhang X, et al. LncRNA PVT1 facilitates tumorigenesis and progression of glioma via regulation of miR-128-3p/GREM1 Axis and BMP signaling pathway. Neurotherapeutics. 2018;15(4):1139–1157.
   PubMed Web of Science ®Google Scholar
• Song Y-N, Shi L-L, Liu Z-Q, et al. Global analysis of the ovarian microRNA transcriptome: implication for miR-2 and miR-133 regulation of oocyte meiosis in the Chinese mitten crab, Eriocheir sinensis (Crustacea:Decapoda). BMC Genomics. 2014;15(1):547–547.
   PubMed Web of Science ®Google Scholar
• Huang MC, Chen LY, Chang HM, et al. Decreased blood levels of oxytocin in ketamine-dependent patients during early abstinence. Front Psychiatry. 2018;9:633.
   PubMed Web of Science ®Google Scholar
• Xue X, Fei X, Hou W, et al. miR-342-3p suppresses cell proliferation and migration by targeting AGR2 in non-small cell lung cancer. Cancer Lett. 2018;412:170–178.
   PubMed Web of Science ®Google Scholar
• James CD. Aberrant miRNA expression in brain tumors: a subject attracting an increasing amount of attention. Neuro Oncol. 2013;15(4):405.
   PubMed Web of Science ®Google Scholar
• Xie Z, Li X, Chen H, et al. The lncRNA-DLEU2/miR-186-5p/PDK3 axis promotes the progress of glioma cells. Am J Transl Res. 2019;11(8):4922–4934.
   PubMed Web of Science ®Google Scholar
• Wang J, Yang Y, Cao Y, et al. miR‑342 inhibits glioma cell proliferation by targeting GPRC5A. Mol Med Rep. 2019;20(1):252–260.
   PubMed Web of Science ®Google Scholar
• Zhang W, Bi Y, Li J, et al. Long noncoding RNA FTX is upregulated in gliomas and promotes proliferation and invasion of glioma cells by negatively regulating miR-342-3p. Lab Invest. 2017;97(4):447–457.
   PubMed Web of Science ®Google Scholar
• Ren XTH, Wu J, Gao TY, et al. Tspan5 inhibits proliferation and migration of JEG-3 cells by inhibiting FAK and AKT phosphorylation. Clin Exp Obstet Gyn. 2019;46:280–284.
   Google Scholar
• Honardoost M, Rad S. Triangle of AKT2, miRNA, and tumorigenesis in different cancers. Appl Biochem Biotechnol. 2018;185(2):524–540.
   PubMed Web of Science ®Google Scholar
• Wang L, Yao J, Zhang X, et al. miRNA-302b suppresses human hepatocellular carcinoma by targeting AKT2. Mol Cancer Res. 2014;12(2):190–202.
   PubMed Web of Science ®Google Scholar
• Xu X, Chen H, Zhang Q, et al. MiR-650 inhibits proliferation, migration and invasion of rheumatoid arthritis synovial fibroblasts by targeting AKT2. Biomed Pharmacother. 2017;88:535–541.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang J, Zhang J, et al. MicroRNA-625 inhibits the proliferation and increases the chemosensitivity of glioma by directly targeting AKT2. Am J Cancer Res. 2017;7(9):1835–1849.
   PubMed Web of Science ®Google Scholar